# The Role of mGluR5 in CBT-I

> **NCT07076342** · PHASE4 · RECRUITING · sponsor: **Stony Brook University** · enrollment: 42 (estimated)

## Conditions studied

- Major Depressive Disorder (MDD)

## Interventions

- **BEHAVIORAL:** Cognitive Behavioral Therapy for Insomnia
- **DRUG:** PET Scan with [11C]ABP688

## Key facts

- **NCT ID:** NCT07076342
- **Lead sponsor:** Stony Brook University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2030-03-31
- **Final completion:** 2030-03-31
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07076342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07076342, "The Role of mGluR5 in CBT-I". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07076342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*